ACMG Issues Clarification Over Incidental Findings Guidance
By Dr Philippa Brice and Dr Ron Zimmern,
PHG Foundation
| 05. 07. 2013
The American College of Medical Genetics (ACMG) has released a
clarification of recent guidance issued on the subject of incidental findings in clinical genomics (see
previous news).
This document aims to address five specific issues that have provoked concerns among commentators: patient autonomy, children, clinical laboratory issues, communication of results, and prediction of disease risk.
The ACMG’s approach to patient autonomy drew the heaviest criticism from PHG Foundation experts (see
previous commentary), who found the recommendation that patients should be obliged to accept the feedback of incidental findings in the form of a set of specific disease-associated genetic variants as a condition of clinical genome sequencing ethically unacceptable. Whilst firmly acknowledging the potential clinical value of offering simultaneous analysis for the presence of these selected variants, the PHG Foundation concluded that failure to offer patients the ability to opt out of such testing or feedback of results was: ‘
a coercive strategy that should have no place in the modern practice of medicine’.
The ACMG has now released further information reiterating that the selected variants they specified...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Katrina Miller, The New York TImes | 02.05.2026
Joseph Yracheta: The Native Biodata Consortium is the first nonprofit data and sample repository within the geographic bounds and legal jurisdiction of an American Indian nation, on the Cheyenne River Sioux Reservation in Eagle Butte, S.D.
NativeBio participated in a ...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...